The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2013Neuroprotectin D1 (NPD1) as a Disease-modifying Therapy for Parkinson’s Disease
Objective/Rationale:
Progressive loss of dopaminergic neurons in Parkinson’s disease (PD) involves several pathogenic mechanisms. It may be assumed that drugs acting on more than one... -
Rapid Response Innovation Awards, 2013Alpha-synuclein Picobody: A Novel Blood-Brain Barrier Permeable Diagnostic Ligand for Parkinson's Disease
Objective/Rationale:
The presence of the blood-brain barrier (BBB) has been an insurmountable impediment to successful drug delivery to the central nervous system. To circumvent the BBB... -
Research Grant, 2013Utility of a Novel Nicotinic Receptor Agonist for Treating Levodopa-induced Dyskinesia
Objective/Rationale:
It has been suggested that a nicotinic acetylcholine receptor (nAChR) agonists may restore the deficits caused by the loss of nicotinic acetylcholine subunits found in Parkinson’s... -
Therapeutic Pipeline Program, 2013Developing Disease-Modifying Therapies to Treat Parkinsons’s Disease by Enhancing the Clearance of Alpha Synuclein
Objective/Rationale:
This proposal seeks to develop a novel therapy that can slow the progression of Parkinson’s disease (PD) by optimizing chemical compounds that can decrease levels of alpha... -
Research Grant, 2013Continuous Subcutaneous Administration of Levodopa/Carbidopa (ND0612) for the Treatment of Parkinson's Disease
Objective/Rationale:
Improving consistency of plasma levodopa has been a longstanding pharmacological challenge. ND0612 is a proprietary formulation of levodopa and carbidopa continuously... -
MJFF Research Grant, 2013Delivery of GDNF to the Brain by Novel Nanovesicles for the Treatment of Parkinson’s Disease (Supplement)
Promising Outcomes of Original Grant:
The overall goal of this project is to develop V-SmartTM nanovesicles for delivering GDNF to the brain as a novel treatment of Parkinson's disease (PD). In the...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.